Navigation Links
QuikByte Software, Inc. Announces Changes to Board of Directors and Executive Ranks
Date:7/7/2008

ware, Inc. may not proceed as contemplated, and by all other matters specified in the QuikByte's filings with the Securities and Exchange Commission. These statements are made based upon current expectations that are subject to risk and uncertainty. QuikByte does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in QuikByte's filings with the Securities and Exchange Commission, including its most recent periodic report. We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA.


'/>"/>
SOURCE QuikByte Software, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. March of Dimes Announces Nursing Scholarship Recipients
2. Zix Corporation Announces Webcast Showcasing Email Encryption Competitive Replacement
3. Digestive Care, Inc. Announces the Filing of the First Module of NDA Submission for PANCRECARB(R) (pancrelipase)
4. Mindray Announces 20-F Filing
5. Mergent, Inc. Announces Changes to the HealthShares(TM) Ophthalmology Index
6. Senetek Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Limited
7. Mylan Announces Tentative FDA Approval for Generic Version of Antibiotic Zyvox(R) Tablets
8. Hooper Holmes Announces Sale of Claims Evaluation Division
9. Transition Therapeutics Announces Executive Management Appointments
10. Chindex International, Inc. Announces Receipt of Key Regulatory ApprovalsChina SFDA Certificates Received Include Intuitive Surgical daVinci S
11. Ambulatory Services of America, Inc. Announces the Acquisition of Dialysis Operations in St. Louis, Missouri
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2015)... ... ... A new Phase I research study is looking at a vaccine that hopes ... G. Lucas, M.D. , chief of the division of pediatric hematology/oncology and stem cell ... Hospital and in the UofL Department of Pediatrics . Patients are currently ...
(Date:8/2/2015)... ... August 03, 2015 , ... For many “would be” entrepreneurs, starting a new business can ... can’t afford to start a business.” Neither needs be a major obstacle. , The ... to start a business and be successful. The risks of starting a business can be ...
(Date:8/2/2015)... (PRWEB) , ... August 02, ... ... results when the supportive muscles and connective tissues of a woman’s pelvic ... weakness and damage include straining, heavy lifting, obesity, constipation, multiple vaginal deliveries, ...
(Date:8/2/2015)... ... August 02, 2015 , ... Molecular biologists in New South Wales ... mesothelioma. Surviving Mesothelioma has just posted an article on the new research. Click ... Wales tested for Ki67 expression in tissue samples from 42 patients with peritoneal mesothelioma ...
(Date:8/1/2015)... ... August 02, 2015 , ... AlignLife Office Coordinator Heather ... continuity of care for patients at this natural health care center in Winamac. , ... Mary Heal said. "Heather's role is vital to our approach because we want to ...
Breaking Medicine News(10 mins):Health News:UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 3Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 4Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 5Health News:Minimally Invasive and Robotic Treatment for Pelvic Organ Prolapse Now Available from the Specialists at Women’s Excellence in Bladder Control 2Health News:Scientists Link Protein Marker with Mesothelioma Prognosis in New Study, According to Surviving Mesothelioma 2Health News:New Patient Advocate Enhances Natural Health Care 2
... of UCSF scientists have received grants from the California ... based strategies for treating diabetes and brain tumors. ... file new drug applications to the U.S. Food and ... clinical trials. The two grants, awarded to collaborative ...
... have DNA that may make things tougher behind the wheel, researchers ... bad driver? Maybe you can blame it on your genes. , ... variation performed 20 percent worse on simulated driving tests and did ... have the variation, the team said. , "These people make more ...
... ... be used to establish the Meharry Clinical and Translational Research Center (MeTRC) to further health ... ... of the National Institutes of Health (NIH), announced today that it will provide $21.4 million ...
... to delays in the nationwide distribution H1N1 flu vaccine, Department ... steps to prevent the spread of illness. , "We ... H1N1 vaccine," Department of Health Deputy Secretary Michael Huff said ... and distribution. "We, too, are frustrated by the production delays. ...
... 29 Although women with chronic hepatitis C virus (HCV) ... compared outcomes for men and women after having liver transplantation ... graft loss and graft loss from recurrent HCV than men. ... HCV and higher risk of developing advanced HCV, our results ...
... energy to stimulate the body,s healing process, are promising ... a number of conditions, reducing anxiety for hospitalized patients ... what standard treatments can achieve. However, longer-term effects are ... of Cancer Prevention and Control Research, and Dr. Paul ...
Cached Medicine News:Health News:UCSF diabetes, brain tumor stem cell grants to drive development of therapies 2Health News:UCSF diabetes, brain tumor stem cell grants to drive development of therapies 3Health News:UCSF diabetes, brain tumor stem cell grants to drive development of therapies 4Health News:Is There a 'Bad Driver' Gene? 2Health News:Meharry Medical College Receives $21.4 Million NIH Research Grant, Largest in Its History 2Health News:Meharry Medical College Receives $21.4 Million NIH Research Grant, Largest in Its History 3Health News:PA Department of Health: National Delays in H1N1 Flu Vaccine Distribution Highlight Need for Continued Prevention Efforts 2Health News:Women Are at Greater Risk Than Men of Graft Loss After Undergoing Liver Transplantation for Hepatitis C-related Liver Disease 2Health News:Women Are at Greater Risk Than Men of Graft Loss After Undergoing Liver Transplantation for Hepatitis C-related Liver Disease 3Health News:Biofield therapies: Helpful or full of hype? 2
(Date:7/30/2015)... July 30, 2015  Amgen (NASDAQ: AMGN ... quarter of 2015. Key results include: , ... quarter of 2014 to $5,370 million, with 6 ... ® (etanercept), Prolia ® (denosumab), Sensipar ... XGEVA ® (denosumab). Unfavorable changes in foreign ...
(Date:7/30/2015)...  Amgen (NASDAQ: AMGN ) today announced the appointment ... Warburg Pincus LLC, to the Amgen Board of Directors. ... and the deep, global experience he brings in the ... Bradway , chairman and chief executive officer of Amgen. "Fred,s breadth ... well." Mr. Hassan has been Partner and Managing ...
(Date:7/30/2015)... CHAGRIN FALLS, Ohio , July 30, 2015 /PRNewswire/ ... in his OMTEC® 2015 keynote address last month that ... business models in order to gain the efficiencies—and develop ... future. Dr. Barsoum,s comments were preceded by ... Tornier, avid entrepreneur and OMTEC moderator, who stressed that ...
Breaking Medicine Technology:Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... (NASDAQ: ARNA ) announced today that ... JMP Securities Healthcare Conference on Tuesday, September 27, 2011, at ... St. Regis New York Hotel in New York City. Jack ... provide a corporate overview. A live audio webcast ...
... Group, Inc.  (OTCBB: MDXG), an integrated developer, manufacturer ... bioimplants processed from human amniotic membrane, announced today ... national, leading distributor of spine, biologic and other ... Administration ("VA") and Department of Defense ("DOD") facilities. ...
Cached Medicine Technology:Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference 2Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference 3MiMedx Group Partners With Affirmative Solutions 2MiMedx Group Partners With Affirmative Solutions 3
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... a 1-step, hand-held, point-of-care device for the qualitative ... urine. The TOX/See device can detect up ... in 3 to 8 minutes and requires only ... is individually packaged to maximize convenience and ease ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... from CTS pain and hand tingling in ... CTS treatments. It is not a rigid ... Solution gently reshapes soft tissue in and ... pain, numbness and sleep interruption. It allows ...
Medicine Products: